Revance Therapeutics shares owned by Schonfeld Strategic Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Schonfeld Strategic Advisors
from 13F filings
Historical chart of Schonfeld Strategic Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Schonfeld Strategic Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.3M | 266k | 8.79 |
| 2023-09-30 | $2.3M | 202k | 11.47 |
| 2023-06-30 | $2.1M | 84k | 25.31 |
| 2023-03-31 | $1.8M | 55k | 32.21 |
| 2022-12-31 | $3.2M | 171k | 18.46 |
| 2022-09-30 | $5.9M | 217k | 27.00 |
| 2021-06-30 | $293k | 9.9k | 29.60 |
| 2018-03-31 | $2.6M | 84k | 30.80 |
| 2017-12-31 | $3.4M | 95k | 35.75 |
More positions owned by Schonfeld Strategic Advisors
View all positions for Schonfeld Strategic Advisors